Dato Capital
Menu
Home Help Pricing Contact us Español
Log In
New User
Dato Capital United Kingdom

Lizann Medical LTD

Download Report
Watch this company

Reports

Full Company ReportLIZANN MEDICAL LIMITED Full Company Report PDF
Includes
  • latest filed accounts (original document), financial statement with balance sheet, assets, etc... (year ending Apr 30, 2024)
  • original incorporation documents (if available)
  • complete list of titles of filed documents
  • full registry information with list of directors and secretaries, addresses and available company phone numbers
  • related company news
  • information about these directors and secretaries in other companies

Financials

Last balance sheet date2024-04-30
Employees£1 0%
Total assets£21,948 -9.11%

Details

Company type Private Limited Company, Active
Company Number 11352187
Universal Entity Code7982-8663-7193-6574
Record last updated Thursday, May 10, 2018 8:30:45 AM UTC
Official Address Flat18 Tilehurt Point Tavy Bridge England Se29uh Thamesmead East
Locality Thamesmead Eastlondon
Region BexleyLondon, England
Postal Code SE29UH
Sector Medical nursing home activities

Charts

Visits

LIZANN MEDICAL LIMITED (United Kingdom)Page visits ©2025 https://en.datocapital.com2023-12024-1001

Directors

Document Type Publication date Download link
Registry May 9, 2018 Appointment of a woman Appointment of a woman

Companies with similar name

Back to Top
Dato Capital
About Us Privacy Policy and GDPRGeneral Cookie PolicyCookie management for this domainTerms of Service Contact us

Search companies and directors from

Worldwide UK Gibraltar Luxembourg Spain Netherlands Curaçao Panama Malta Cayman Islands British Virgin Islands VenezuelaBermudaMexicoCosta Rica
Member of the Association of Independent Information Professionals A member company of the Spanish Consumption Arbitration System, with code 413
Dato Capital on X
©2007-2025 DATO CAPITAL LTD United Kingdom (London WC2H 9JQ)
Cookie Policy We use cookies (including third party cookies) to improve navigation. Continuing browsing you consent to receive them. More information in our Cookie policy